Memory Pharmaceuticals
company
About
Memory Pharmaceuticals is focused on developing drug candidates for the treatment of central nervous system conditions.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Neuroscience,Pharmaceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Memory Pharmaceuticals has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Mar 16, 2007 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 16, 2007 | Post-IPO Debt | $10M | 1 |
Hercules Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Memory Pharmaceuticals is funded by 1 investors.
Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
